secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001641172-25-026815
Event type: regulatory
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical receives FDA 510(k) clearance for LIBERTY Endovascular Robotic System
--------------------------------------------------------------------------------

- FDA 510(k) clearance for LIBERTY System, first single-use remotely operated robotic system for peripheral endovascular procedures.
- Pivotal study showed 100% robotic navigation success and zero device-related adverse events; 92% relative reduction in physician radiation exposure.
- Plans to commence commercialization in Q4 2025; initial U.S. addressable market of ~2.5M peripheral vascular procedures annually.
- CEO Harel Gadot to present at H.C. Wainwright Annual Investor Conference on Sept 9, 2025 at 9 AM ET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000164117225026815/0001641172-25-026815-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000164117225026815/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-026815

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer